CN1159933A - Litong oral liquid and preparation method thereof - Google Patents

Litong oral liquid and preparation method thereof Download PDF

Info

Publication number
CN1159933A
CN1159933A CN 96122239 CN96122239A CN1159933A CN 1159933 A CN1159933 A CN 1159933A CN 96122239 CN96122239 CN 96122239 CN 96122239 A CN96122239 A CN 96122239A CN 1159933 A CN1159933 A CN 1159933A
Authority
CN
China
Prior art keywords
oral liquid
preparation
add water
grams
sweeting agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 96122239
Other languages
Chinese (zh)
Inventor
马以骝
陈忠
李保平
陈昆昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Original Assignee
FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL filed Critical FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Priority to CN 96122239 priority Critical patent/CN1159933A/en
Publication of CN1159933A publication Critical patent/CN1159933A/en
Pending legal-status Critical Current

Links

Abstract

An oral liquid for treating prostatic diseases, urethra infection, pyelonephritis, and renal calculus with distinct curative effect and no toxic by-effect is prepared from 7 Chinese-medicinal materials such as plantain seed, smilax glabra rhizoma, wild chrysanthemum flower, ricepaper pith, umbellate pore-fungus, etc.

Description

Sharp logical oral liquid and preparation method thereof
The present invention relates to the pharmaceutical production technical field, specifically sharp logical oral liquid and preparation method thereof.
For diseases such as treatment prostatosis, urinary tract infection, kidney pancreas nephritis, renal calculuss, doctor trained in Western medicine generally adopts diuresis, antiinflammatory, the treatment of methods such as kalium replenishment at present.But to hypertension, patients such as heart failure are favorable factor not, easily produces the effect of paying.
The purpose of this invention is to provide a kind of good effect, easy to use, and above-mentioned patient is not had logical oral liquid of profit of the effect of paying and preparation method thereof.
The present invention is this realization: the prescription of sharp logical oral liquid contains Semen Plantaginis 10-20%, Rhizoma Smilacis Glabrae 15-25%, Flos Chrysanthemi Indici 10-20%, Medulla Tetrapanacis 7-11%, Polyporus 15-25%, Fructus Liquidambaris 9-18%, Radix Ginseng 2-6%, an amount of sweeting agent.
Its preparation method is: the described raw material of claim 1 is abandoned impurity stone roller powder put in the decocting medicine pot, add water logging and cross powder, boil filtration in 1 hour, medicinal residues add water again and repeat decoction filtering once, are concentrated in right amount with preceding decoction amalgamation liquid, add sweeting agent, packing, sterilization promptly.
The present invention is described in further detail below in conjunction with embodiment:
Embodiment 1:
With Semen Plantaginis 100 grams, Rhizoma Smilacis Glabrae 125 grams, Flos Chrysanthemi Indici 100 grams, Medulla Tetrapanacis 60 grams, Polyporus 125 grams, Fructus Liquidambaris 90 grams, Radix Ginseng 25 grams are abandoned impurity with them and are ground powder, put in the decocting medicine pot, add water logging and cross powder, boil 1 hour, filter.Medicinal residues add water again to be repeated to decoct once, filters, and merges with preceding decoction liquor to be concentrated in right amount, and the adding sweeting agent is an amount of, adds distillate to capacity, packing, and sterilization is promptly.
Embodiment 2:
With Semen Plantaginis 200 gram, Rhizoma Smilacis Glabrae 150 grams, Flos Chrysanthemi Indici 100 grams, Medulla Tetrapanacis 60 grams, Polyporus 125 grams, Fructus Liquidambaris 90 grams, Radix Ginseng 25 grams, Mel is an amount of, they is abandoned impurity grind powder, uses the method identical with embodiment 1 to make.
Oral liquid of the present invention has warm penting up, clearing away heat-fire, and the parasite killing diuresis, the effect that eliminating dampness by diuresis is treating stranguria, for prostatosis, urinary tract infection, kidney pancreas nephritis, renal calculus etc. have obvious therapeutic efficiency.Have and strengthen the effect that relieving stranguria by diuresis, invigorating the spleen and replenishing QI, warming middle-JIAO have to be had in falling, falling liter, ooze the eliminating cold for resuscitation key.Through nontoxic pair of effect of acute toxicity testing proof, safe and reliable, easy to use, easily accept for patient.
Below be the acute toxicity testing report of oral liquid of the present invention:

Claims (2)

1, the logical oral liquid of a kind of profit is characterized in that containing Semen Plantaginis 10-20%, Rhizoma Smilacis Glabrae 15-25%, Flos Chrysanthemi Indici 10-20%, Medulla Tetrapanacis 7-11%, Polyporus 15-25%, Fructus Liquidambaris 9-18%, Radix Ginseng 2-6%, an amount of sweeting agent.
2, the preparation method of the logical oral liquid of a kind of profit, it is characterized in that the described raw material of claim 1 is abandoned impurity stone roller powder to be put in the decocting medicine pot, add water logging and cross powder, boil filtration in 1 hour, medicinal residues add water again and repeat decoction filtering once, are concentrated in right amount with preceding decoction amalgamation liquid, add sweeting agent, packing, sterilization promptly.
CN 96122239 1996-11-07 1996-11-07 Litong oral liquid and preparation method thereof Pending CN1159933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96122239 CN1159933A (en) 1996-11-07 1996-11-07 Litong oral liquid and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96122239 CN1159933A (en) 1996-11-07 1996-11-07 Litong oral liquid and preparation method thereof

Publications (1)

Publication Number Publication Date
CN1159933A true CN1159933A (en) 1997-09-24

Family

ID=5127194

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96122239 Pending CN1159933A (en) 1996-11-07 1996-11-07 Litong oral liquid and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1159933A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1064547C (en) * 1998-04-06 2001-04-18 游文新 Capsule for treating prostate diseases and preparation process
WO2004084924A1 (en) * 2003-03-28 2004-10-07 Beijing Wonner Biotech Ltd. Co. Pharmaceutical composition for treatment of bph and preparation thereof
CN1935194B (en) * 2006-06-30 2011-11-09 杨雄志 Preparation method of Chinese medicine composition for treating nephroma

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1064547C (en) * 1998-04-06 2001-04-18 游文新 Capsule for treating prostate diseases and preparation process
WO2004084924A1 (en) * 2003-03-28 2004-10-07 Beijing Wonner Biotech Ltd. Co. Pharmaceutical composition for treatment of bph and preparation thereof
US7556828B2 (en) 2003-03-28 2009-07-07 Zuguang Zhang Pharmaceutical composition for treatment of BPH and preparation thereof
CN1935194B (en) * 2006-06-30 2011-11-09 杨雄志 Preparation method of Chinese medicine composition for treating nephroma

Similar Documents

Publication Publication Date Title
CN1303692A (en) Toxin-discharging liver-fortifying medicine
CN1159933A (en) Litong oral liquid and preparation method thereof
CN1131050C (en) Medicinal particles for treating diabetic peripheral neuropathy
CN1203092A (en) Anticancer oral liquor and its preparing process
CN1907318A (en) Use of ceylon houndstongue and pharmaceutical composition containing same
CN1057227C (en) Oral liquid for removing intense heat from throat and preparing process thereof
CN1059345C (en) External use medicine for treating myopia
CN1235628C (en) Lithagogue decoction
CN1207025C (en) Haidan medicine for treating cardiac and cerebral vascular diseases and its prepn
CN102580023A (en) Medicament for treating disorder of spleen and stomach and abdominal swelling and pain
CN1352948A (en) Prescription and preparing process of medicine for treating renal calculus
CN1325105C (en) Oral liquid for clearing liver and gallbladder
CN101380414B (en) Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof
CN1274357C (en) Chinese patent drug for treatnig liver fibration and cirrhosis, preparing method for its preparation
CN1031781C (en) Making method of strong thrombus-dissolving capsule
CN1157157A (en) Traditional Chinese medicine composition for curing rheumatism and its preparation method
CN1772143A (en) Gout treating medicine
CN1152700C (en) Capsule for treating headache
CN1301130C (en) Hepatic calculus dissolving solution
CN1088999C (en) Process for preparing medicine to cure rheumatoid arthritis
CN1277552C (en) Five ingredients kaladana containing capsule and preparation technique thereof
CN1251725C (en) Quick-acting haemorrhoids ointment (suppository)
CN1055212C (en) Quick-acting blood-coagulating preparation made from traditional Chinese medicine
CN1057699C (en) Capsule for treating apoplexy sequela and its producing method
CN1280847A (en) Process for preparing medical wine to treat rheumatic arthritis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication